← Back to Clinical Trials
Recruiting NCT06573320

NCT06573320 Effect of Exercise on Clinical Symptoms, Cognitive Performance, and Quality of Life in Schizophrenia Patients Treated With Clozapine

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06573320
Status Recruiting
Phase
Sponsor Dr. Lutfi Kirdar Kartal Training and Research Hospital
Condition Schizophrenia
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-03-14
Primary Completion 2024-08-26

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
physical exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-03-14 with a primary completion date of 2024-08-26.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective study aims to investigate the effects of exercise on clinical symptoms, cognitive performance, and quality of life in schizophrenia patients treated with Clozapine.

Eligibility Criteria

Inclusion Criteria: * Patients treated who were diagnosed with schizophrenia according to DSM-V criteria by psychiatrist at the Turkish Ministry of Health Kartal Dr. Lütfi Kırdar City Hospital * using a therapeutic dose of 300-500 mg/day of clozapine, Exclusion Criteria: * pregnancy

Contact & Investigator

Central Contact

Ebru Akbuga Koc

✉ ebruakbuga@gmail.com

📞 0216

Frequently Asked Questions

Who can join the NCT06573320 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Schizophrenia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06573320 currently recruiting?

Yes, NCT06573320 is actively recruiting participants. Contact the research team at ebruakbuga@gmail.com for enrollment information.

Where is the NCT06573320 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06573320 clinical trial?

NCT06573320 is sponsored by Dr. Lutfi Kirdar Kartal Training and Research Hospital. The trial plans to enroll 60 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology